Terms: = Liver cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1958 results:
1. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate egfr signaling and recycling.
Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H
J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188
[TBL] [Abstract] [Full Text] [Related]
2. Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Wang DS; Ren C; Li SS; Fong WP; Wu XJ; Xiao J; Li BK; Zheng Y; Ding PR; Chen G; Qiu MZ; Wang ZQ; Wang FH; Luo HY; Wang F; Wang XZ; Wang LY; Xie DJ; Chen T; Li LR; Lu ZH; Zhai XH; Liu TS; Yuan Y; Chen JQ; Tan Q; Pan ZZ; Wan DS; Zhang R; Yuan YF; Xu RH; Li YH
PLoS Med; 2024 May; 21(5):e1004389. PubMed ID: 38728364
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
[TBL] [Abstract] [Full Text] [Related]
4. Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
Yang JD; Liu YC; Wang HC; Hsu FT; Liao TL; Huang MC; Chen JH
In Vivo; 2024; 38(3):1079-1093. PubMed ID: 38688627
[TBL] [Abstract] [Full Text] [Related]
5. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via egfr Signaling in the cancer Microenvironment.
Kubo T; Nishimura N; Kaji K; Tomooka F; Shibamoto A; Iwai S; Suzuki J; Kawaratani H; Namisaki T; Akahane T; Yoshiji H
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673992
[TBL] [Abstract] [Full Text] [Related]
6. Network toxicology and molecular docking for the toxicity analysis of food contaminants: A case of Aflatoxin B
Chu ZY; Zi XJ
Food Chem Toxicol; 2024 Jun; 188():114687. PubMed ID: 38663764
[TBL] [Abstract] [Full Text] [Related]
7. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
[TBL] [Abstract] [Full Text] [Related]
8. Anti-egfr Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal cancer: A Nonrandomized Controlled Trial.
Ciardiello D; Martinelli E; Troiani T; Mauri G; Rossini D; Martini G; Napolitano S; Famiglietti V; Del Tufo S; Masi G; Santini D; Avallone A; Pietrantonio F; Lonardi S; Di Maio M; Zampino MG; Fazio N; Bardelli A; Siena S; Cremolini C; Sartore-Bianchi A; Ciardiello F
JAMA Netw Open; 2024 Apr; 7(4):e245635. PubMed ID: 38592721
[TBL] [Abstract] [Full Text] [Related]
9. Epidemiology of NAFLD - Focus on diabetes.
Younossi ZM; Henry L
Diabetes Res Clin Pract; 2024 Apr; 210():111648. PubMed ID: 38569945
[TBL] [Abstract] [Full Text] [Related]
10. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract] [Full Text] [Related]
11. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
12. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased egfr expression by activating AhR and Akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
13. The new N
Liu J; Nie W; Nie H; Yao H; Ren Y; Cao L; Qiu J; Wang M; Li X; An B; Jia X
Bioorg Chem; 2024 May; 146():107313. PubMed ID: 38554675
[TBL] [Abstract] [Full Text] [Related]
14. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
15. Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sitthideatphaiboon P; Nantavithya C; Chantranuwat P; Vinayanuwattikun C; Sriuranpong V
Sci Rep; 2024 Mar; 14(1):6146. PubMed ID: 38480816
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis of Sorafenib-Ruthenium Complexes, Investigation of Biological Activities and Applications in Drug Delivery Systems as an Anticancer Agent.
Zengin Kurt B; Öztürk Civelek D; Çakmak EB; Kolcuoğlu Y; Şenol H; Sağlık Özkan BN; Dag A; Benkli K
J Med Chem; 2024 Mar; 67(6):4463-4482. PubMed ID: 38471014
[TBL] [Abstract] [Full Text] [Related]
17. Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease.
Yang X; Lin Y; Huang J; Chi Y; Wu Y; Lin S
Sci Rep; 2024 Mar; 14(1):5923. PubMed ID: 38467667
[TBL] [Abstract] [Full Text] [Related]
18. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
Yu L; Zhang M; He J; Sun X; Ni P
Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
[TBL] [Abstract] [Full Text] [Related]
19. Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
20. Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline-isoxazole-piperazine conjugates as egfr-targeting agents.
Ali MI; Thirukovela NS; Kumar GB; Dasari G; Badithapuram V; Manchal R; Bandari S
Chem Biol Drug Des; 2024 Mar; 103(3):e14499. PubMed ID: 38444047
[TBL] [Abstract] [Full Text] [Related]
[Next]